상단으로
Choose your location
Select your country or region to view content specific to your country.
Choose your country
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
'MEDICA 2012' in Dusseldorf, Germany
Nov 17, 2012
Seegene Inc. has recently participated in MEDICA 2012, which was held in Dusseldorf, Germany from November 14-17th, 2012.
MEDICA is a global event for corporations and buyers in the medical devices industry, at which accounts for the year are settled and business plans and sales goals for the following year established. This year, 4,500 participants from 60 different countries were in attendance. Seegene Inc. has been participating this exhibition for 7 years as it is a good opportunity to discuss the sales activities of its distributors and to further activate global sales by discovering possible future distributors in countries which have shown low sales activities. At Medica. Seegene introduced its new product, Anyplex™ II, based on TOCE™ technology, which detects respiratory viruse infections, HPV (human papilloma virus), STIs (sexually transmitted diseases), and MTB infection & anti-TB drug resistance. In addition, Seegene was in the spotlight when it introduced its automatic test solution for molecular diagnostics,which are automated extraction real-time amplification test system (CFX96), and software to enable the easy readout of multiplex test results.
MEDICA is a global event for corporations and buyers in the medical devices industry, at which accounts for the year are settled and business plans and sales goals for the following year established. This year, 4,500 participants from 60 different countries were in attendance. Seegene Inc. has been participating this exhibition for 7 years as it is a good opportunity to discuss the sales activities of its distributors and to further activate global sales by discovering possible future distributors in countries which have shown low sales activities. At Medica. Seegene introduced its new product, Anyplex™ II, based on TOCE™ technology, which detects respiratory viruse infections, HPV (human papilloma virus), STIs (sexually transmitted diseases), and MTB infection & anti-TB drug resistance. In addition, Seegene was in the spotlight when it introduced its automatic test solution for molecular diagnostics,which are automated extraction real-time amplification test system (CFX96), and software to enable the easy readout of multiplex test results.